Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2024.08- Associate Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11-2024.07 Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
應用深度學習與放射組學技術，精確預測立體定向放射外科手術後的局部腦部復發
Lee, H.-L. (PI)
1/1/26 → 12/31/26
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Exploring the Radiotherapeutic Potentiation of Nanoformulated Zerumbone in Proton Therapy for Head and Neck Cancer: Mechanistic Insights, Formulation Development, and Translational Perspectives
Lee, H.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
應用深度學習與放射組學技術，精確預測立體定向放射外科手術後的局部腦部復發
Lee, H.-L. (PI)
1/1/25 → 12/31/25
Project: B - Project of TMU › i - Other (Funded by TMU)
-
The Development of Combined Hyperthermia and Proton Therapy to Overcome the Metabolic Compensation in Radioresistant Head and Neck Squamous Cell Carcinoma
Lee, H.-L. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
針對缺氧相關因子與緩激肽B1 受體-水通道蛋白4 訊號軸以克服多形性膠質母細胞瘤放射拮抗性之研究
Lee, H.-L. (PI)
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth
Tsai, Y. T., Yen, M. H., Hu, P. J., Lee, C. C., Liu, C. Y., Cheng, T. M., Shen, H. T., Benjamin Zhang, B. X., Lee, H. L., Chuang, K. H., Yap, C. V., Wang, W. C. & Wu, M. H., Jun 28 2026, In: Cancer Letters. 648, 218463.Research output: Contribution to journal › Article › peer-review
-
Critical radiosensitizing parameters of dual-modality gold nanodandelion against cancer radioresistance in MV X-ray and proton therapies
Chuang, Y. C., Chiou, J. F., Wu, P. H., Shen, Y. A., Chang, W. M., Hsia, Y., Kuo, C. C., Wang, W. J., Lo, L. W. & Lee, H. L., Jun 2026, In: Materials Today Advances. 30, 100757.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinoma
Kuo, C. C., Chuang, Y. C., Wu, P. H., Chang, W. M., Lo, L. W., Chen, H. Y., Lee, K. H., Lee, H. L., Chiou, J. F. & Shen, Y. A., 2026, (Accepted/In press) In: Nanoscale.Research output: Contribution to journal › Article › peer-review
-
ACSL6 modulates docosahexaenoic acid-induced cytotoxicity to potentiate chemotherapy response in colorectal and breast cancer
Chen, I. S., Hsieh, C. C., Li, C. C., Wei, Y. L., Cheng, C. C., Feng, S. W., Lee, H. L., Chiang, N. J., Shen, C. H. & Hsu, H. P., Dec 2025, In: Oncogenesis. 14, 1, 45.Research output: Contribution to journal › Article › peer-review
Open Access -
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation
Wu, M. S., Kao, W. Y., Chiang, M. F., Chuang, P. H., Hsu, S. J., Wang, S. Y., Chang, C. W., Lin, C. C., Hung, C. H., Wu, C. H., Chen, S. C., Lee, H. L., Hwang, J. I., Liang, P. C., Lin, S. M. & Wang, C. C., 2025, (Accepted/In press) In: Liver Cancer. 15, 1, p. 149-164 16 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)
Datasets
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Wen, Y.-C. (Creator), Lee, L.-M. (Creator), Lin, Y.-W. (Creator), Syu, S.-H. (Creator), Lin, K.-H. (Creator), Fan, Y.-C. (Creator), Lee, H.-L. (Creator), Lai, B. C. H. (Creator) & Shih, H.-J. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17009635.v1, https://tandf.figshare.com/articles/journal_contribution/Loco-regional_deep_hyperthermia_combined_with_intravesical_Mitomycin_instillation_reduces_the_recurrence_of_non-muscle_invasive_papillary_bladder_cancer/17009635/1
Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J.-M. (Contributor), Yan, J.-L. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Lai, I.-C. (Contributor), Yao, C.-J. (Contributor), Lai, G.-M. (Contributor), Bai, K.-J. (Contributor), Chuang, S.-E. (Contributor) & Li, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G.-M. (Contributor), Li, C.-H. (Contributor), Yeh, C.-F. (Creator), Whang-Peng, J. (Creator), Lee, H.-L. (Contributor), Yao, C.-J. (Contributor), Lai, I.-C. (Contributor), Chuang, S.-E. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor) & Yan, J.-L. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S.-E. (Contributor), Lai, I.-C. (Contributor), Yeh, C.-F. (Creator), Yan, J.-L. (Contributor), Yao, C.-J. (Contributor), Whang-Peng, J. (Creator), Li, C.-H. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor), Lee, H.-L. (Contributor) & Lai, G.-M. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
Dataset